BioRegenx Announces Glycocalyx Biomarkers in Children Study Using Its Medical Testing Device GlycoCheck
CHATTANOOGA, TN / ACCESSWIRE / February 6, 2023 / BioRegenx, Inc. which has entered into a Definitive Agreement to merge with Findit, Inc, and its...
BioRegenx Announces Study of Glycocalyx Damage from Kidney Patients’ Plasma and Its Restoration with Endocalyx Pro
CHATTANOOGA, TN / ACCESSWIRE / January 4, 2023 / BioRegenx, Inc. which has entered into a Definitive Agreement to merge with Findit, Inc, and its...
Findit, Inc. and BioRegenx, Inc. Announce they have Entered into a Definitive Agreement to Merge:
ATLANTA, GA / ACCESSWIRE / December 29, 2022 / Findit, Inc., a Nevada Corporation (OTC PINK:FDIT), owner of Findit.com, a full-service social networking platform that...